Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Intervalo de año de publicación
1.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;44(6): 538-545, June 2011. ilus
Artículo en Inglés | LILACS | ID: lil-589976

RESUMEN

β-ionone (βI), a cyclic isoprenoid, and geraniol (GO), an acyclic monoterpene, represent a promising class of dietary chemopreventive agents against cancer, whose combination could result in synergistic anticarcinogenic effects. The chemopreventive activities of βI and GO were evaluated individually or in combination during colon carcinogenesis induced by dimethylhydrazine in 48 3-week-old male Wistar rats (12 per group) weighing 40-50 g. Animals were treated for 9 consecutive weeks with βI (16 mg/100 g body weight), GO (25 mg/100 g body weight), βI combined with GO or corn oil (control). Number of total aberrant crypt foci (ACF) and of ACF ≥4 crypts in the distal colon was significantly lower in the GO group (66 ± 13 and 9 ± 2, respectively) compared to control (102 ± 9 and 17 ± 3) and without differences in the βI (91 ± 11 and 14 ± 3) and βI+GO groups (96 ± 5 and 19 ± 2). Apoptosis level, identified by classical apoptosis morphological criteria, in the distal colon was significantly higher in the GO group (1.64 ± 0.06 apoptotic cells/mm²) compared to control (0.91 ± 0.07 apoptotic cells/mm²). The GO group presented a 0.7-fold reduction in Bcl-2 protein expression (Western blot) compared to control. Colonic mucosa concentrations of βI and GO (gas chromatography/mass spectrometry) were higher in the βI and GO groups, respectively, compared to the control and βI+GO groups. Therefore, GO, but not βI, represents a potential chemopreventive agent in colon carcrvpdate=20110329inogenesis. Surprisingly, the combination of isoprenoids does not represent an efficient chemopreventive strategy.


Asunto(s)
Animales , Masculino , Ratas , Anticarcinógenos/uso terapéutico , Neoplasias del Colon/prevención & control , Norisoprenoides/uso terapéutico , Terpenos/uso terapéutico , Anticarcinógenos/farmacocinética , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinógenos , Colon/metabolismo , Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/metabolismo , Dimetilhidrazinas , Ensayos de Selección de Medicamentos Antitumorales/métodos , Mucosa Intestinal/metabolismo , Norisoprenoides/farmacocinética , Ratas Wistar , Terpenos/farmacocinética
2.
Braz J Med Biol Res ; 44(6): 538-45, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21445532

RESUMEN

ß-ionone (ßI), a cyclic isoprenoid, and geraniol (GO), an acyclic monoterpene, represent a promising class of dietary chemopreventive agents against cancer, whose combination could result in synergistic anticarcinogenic effects. The chemopreventive activities of ßI and GO were evaluated individually or in combination during colon carcinogenesis induced by dimethylhydrazine in 48 3-week-old male Wistar rats (12 per group) weighing 40-50 g. Animals were treated for 9 consecutive weeks with ßI (16 mg/100 g body weight), GO (25 mg/100 g body weight), ßI combined with GO or corn oil (control). Number of total aberrant crypt foci (ACF) and of ACF ≥4 crypts in the distal colon was significantly lower in the GO group (66 ± 13 and 9 ± 2, respectively) compared to control (102 ± 9 and 17 ± 3) and without differences in the ßI (91 ± 11 and 14 ± 3) and ßI+GO groups (96 ± 5 and 19 ± 2). Apoptosis level, identified by classical apoptosis morphological criteria, in the distal colon was significantly higher in the GO group (1.64 ± 0.06 apoptotic cells/mm²) compared to control (0.91 ± 0.07 apoptotic cells/mm²). The GO group presented a 0.7-fold reduction in Bcl-2 protein expression (Western blot) compared to control. Colonic mucosa concentrations of ßI and GO (gas chromatography/mass spectrometry) were higher in the ßI and GO groups, respectively, compared to the control and ßI+GO groups. Therefore, GO, but not ßI, represents a potential chemopreventive agent in colon carcinogenesis. Surprisingly, the combination of isoprenoids does not represent an efficient chemopreventive strategy.


Asunto(s)
Anticarcinógenos/uso terapéutico , Neoplasias del Colon/prevención & control , Norisoprenoides/uso terapéutico , Terpenos/uso terapéutico , Monoterpenos Acíclicos , Animales , Anticarcinógenos/farmacocinética , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinógenos , Colon/metabolismo , Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/metabolismo , Dimetilhidrazinas , Ensayos de Selección de Medicamentos Antitumorales/métodos , Mucosa Intestinal/metabolismo , Masculino , Norisoprenoides/farmacocinética , Ratas , Ratas Wistar , Terpenos/farmacocinética
3.
Toxicol In Vitro ; 22(2): 510-4, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18077131

RESUMEN

Epidemiological studies have provided evidence that high consumption of tomatoes effectively reduces the risk of reactive oxygen species (ROS)-mediated diseases such as cancer. Tomatoes are rich sources of lycopene, a potent singlet oxygen-quenching carotenoid. In addition to its antioxidant properties, lycopene shows an array of biological effects including antimutagenic and anticarcinogenic activities. In the present study, the chemopreventive action of lycopene was examined on DNA damage and clastogenic or aneugenic effects of H2O2 and n-nitrosodiethylamine (DEN) in the metabolically competent human hepatoma cell line (HepG2 cells). Lycopene at concentrations of 10, 25, and 50 microM, was tested under three protocols: before, simultaneously, and after treatment with the mutagen, using the comet and micronucleus assays. Lycopene significantly reduced the genotoxicity and mutagenicity of H2O2 in all of the conditions tested. For DEN, significant reductions of primary DNA damage (comet assay) were detected when the carotenoid (all of the doses) was added in the cell culture medium before or simultaneously with the mutagen. In the micronucleus test, the protective effect of lycopene was observed only when added prior to DEN treatment. In conclusion, our results suggest that lycopene is a suitable agent for preventing chemically-induced DNA and chromosome damage.


Asunto(s)
Antimutagênicos/farmacología , Carotenoides/farmacología , Línea Celular , Aberraciones Cromosómicas/efectos de los fármacos , Ensayo Cometa , Citocinesis , ADN/biosíntesis , ADN/genética , Daño del ADN/efectos de los fármacos , Dietilnitrosamina/toxicidad , Humanos , Peróxido de Hidrógeno/toxicidad , Licopeno , Pruebas de Micronúcleos , Mutágenos/toxicidad , Oxidantes/toxicidad
4.
Toxicol In Vitro ; 21(5): 840-5, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17350795

RESUMEN

Lycopene is a natural pigment synthesized by plants and microorganisms, and it is mainly found in tomatoes. It is an acyclic isomer of beta-carotene and one of the most potent antioxidants. Several studies have demonstrated the ability of lycopene to prevent chemically induced DNA damage; however, the mechanisms involved are still not clear. In the present study, we investigated the antigenotoxic/antimutagenic effects of lycopene in Chinese Hamster Ovary Cells (CHO) treated with hydrogen peroxide, methylmethanesulphonate (MMS), or 4-nitroquinoline-1-oxide (4-NQO). Lycopene (97%), at final concentrations of 10, 25, and 50 microM, was tested under three different protocols: before, simultaneously, and after the treatment with the mutagens. Comet and cytokinesis-block micronucleus assays were used to evaluate the level of DNA damage. Data showed that lycopene reduced the frequency of micronucleated cells induced by the three mutagens. However, this chemopreventive activity was dependent on the concentrations and treatment schedules used. Similar results were observed in the comet assay, although some enhancements of primary DNA damage were detected when the carotenoid was administered after the mutagens. In conclusion, our findings confirmed the chemopreventive activity of lycopene, and showed that this effect occurs under different mechanisms.


Asunto(s)
Antimutagênicos/farmacología , Carotenoides/farmacología , Daño del ADN , 4-Nitroquinolina-1-Óxido/toxicidad , Animales , Células CHO , Rotura Cromosómica/efectos de los fármacos , Ensayo Cometa , Cricetinae , Cricetulus , ADN/efectos de los fármacos , ADN/ultraestructura , Peróxido de Hidrógeno/toxicidad , Licopeno , Metilmetanosulfonato/toxicidad , Pruebas de Micronúcleos , Mutágenos/toxicidad
5.
Food Chem Toxicol ; 42(10): 1687-93, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15354320

RESUMEN

Annatto (Bixa orellana L.) is a natural food colorant extensively used in many processed foods, especially dairy products. The lower cost of production and the low toxicity, make annatto a very attractive and convenient pigment in substitution to the many synthetic colorants. In the present study we investigate the carcinogenic and anticarcinogenic effects of dietary annatto in Wistar rat liver using the preneoplastic glutathione S-transferase (GST-P) foci and DNA damage biomarkers. Annatto, containing 5% bixin, was administered in the diet at concentrations of 20, 200, and 1000 ppm (0.07; 0.80 and 4.23 bixin/kg body wt/day, respectively), continuously during 2 weeks before, or 8 weeks after DEN treatment (200 mg/kg body wt, i.p.), to evaluate its effect on the liver-carcinogenesis medium-term bioassay. The comet assay was used to investigate the modifying potential of annatto on DEN (20 mg/kg body wt)-induced DNA damage. The results showed that annatto was neither genotoxic nor carcinogenic at the highest concentration tested (1000 ppm). No protective effects were also observed in both GST-P foci development and comet assays. In conclusion, in such experimental conditions, annatto shows no hepatocarcinogenic effect or modifying potential against DEN-induced DNA damage and preneoplastic foci in the rat liver.


Asunto(s)
Anticarcinógenos , Carcinógenos , Colorantes de Alimentos/farmacología , Colorantes de Alimentos/toxicidad , Neoplasias Hepáticas/inducido químicamente , Neoplasias Hepáticas/prevención & control , Extractos Vegetales/farmacología , Extractos Vegetales/toxicidad , Animales , Bixaceae , Peso Corporal/efectos de los fármacos , Carotenoides , Ensayo Cometa , Daño del ADN , Dietilnitrosamina/toxicidad , Ingestión de Alimentos/efectos de los fármacos , Glutatión Transferasa/biosíntesis , Glutatión Transferasa/genética , Hepatectomía , Inmunohistoquímica , Hígado/patología , Neoplasias Hepáticas/patología , Masculino , Ratas , Ratas Wistar , Aumento de Peso
6.
Genet. mol. res. (Online) ; Genet. mol. res. (Online);2(3): 295-308, Sept. 2003.
Artículo en Inglés | LILACS | ID: lil-417600

RESUMEN

The effects of crude extracts of the mushroom Agaricus blazei Murrill (Agaricaceae) on both DNA damage and placental form glutathione S-transferase (GST-P)-positive liver foci induced by diethylnitrosamine (DEN) were investigated. Six groups of adult male Wistar rats were used. For two weeks, animals of groups 3 to 6 were treated with three aqueous solutions of A. blazei (mean dry weight of solids being 1.2, 5.6, 11.5 and 11.5 mg/ml, respectively). After this period, groups 2 to 5 were given a single ip injection 200 mg/kg DEN and groups 1 and 6 were treated with 0.9 NaCl. All animals were subjected to 70 partial hepatectomy at week five and sacrificed 4, 24 and 48 h or 8 weeks after DEN or 0.9 NaCl treatments (10th week after the beginning of the experiment). The alkaline comet assay and GST-P-positive liver foci development were used to evaluate the influence of the mushroom extracts on liver cell DNA damage and on the initiation of liver carcinogenesis, respectively. Previous treatment with the highest concentration of A. blazei (11.5 mg/ml) significantly reduced DNA damage, indicating a protective effect against DEN-induced liver cytotoxicity/genotoxicity. However, the same dose of mushroom extract significantly increased the number of GST-P-positive liver foci


Asunto(s)
Animales , Masculino , Agaricus/química , Anticarcinógenos/farmacología , Daño del ADN/efectos de los fármacos , Glutatión Transferasa/efectos de los fármacos , Neoplasias Hepáticas Experimentales/prevención & control , Carcinógenos , Ensayo Cometa , Dietilnitrosamina , Ensayos de Selección de Medicamentos Antitumorales , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/patología , Glutatión Transferasa/análisis , Neoplasias Hepáticas Experimentales/inducido químicamente , Neoplasias Hepáticas Experimentales/enzimología , Ratas , Ratas Wistar
7.
J Ethnopharmacol ; 83(1-2): 25-32, 2002 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12413704

RESUMEN

The modifying potential of prior administration of an aqueous extract of the mushroom Agaricus blazei Murrill (Agaricaceae) (Ab) on hepatotoxicity induced by different doses of diethylnitrosamine (DEN) in male Wistar rats was evaluated. During 2 weeks, animals of groups G3 (Ab+DEN(50)), G5 (Ab+DEN(100)), G7 (Ab+DEN(200)), and G8 (Ab-treated) were treated with the A. blazei through drinking water. After this period, groups G2 (DEN(50)), G3 (Ab+DEN(50)), G4 (DEN(100)) G5 (Ab+DEN(100)), G6 (DEN(200)), and G7 (Ab+DEN(200)) were given a single i.p. injection of 50, 100 and 200 mg/kg of DEN, respectively, while groups G1 (non-treated) and G8 (Ab-treated) were treated with 0.9% NaCl only. All animals were killed 48 h after DEN or NaCl treatments. The hepatocyte replication rate was estimated by the index of the proliferating cell nuclear antigen (PCNA) positive hepatocytes and the appearance of putative preneoplastic hepatocytes through expression of the enzyme glutathione S-transferase placental form (GST-P). After DEN-treatment, ALT levels, PCNA labeling index, and the number of GST-P positive hepatocytes were lower in rats that received A. blazei treatment and were exposed to 100 mg/kg of DEN. Our findings suggest that previous treatment with A. blazei exerts a hepatoprotective effect on both liver toxicity and hepatocarcinogenesis process induced by a moderately toxic dose of DEN.


Asunto(s)
Agaricus , Antioxidantes/uso terapéutico , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Fitoterapia , Extractos Vegetales/uso terapéutico , Animales , Antioxidantes/administración & dosificación , Antioxidantes/farmacología , Dietilnitrosamina/administración & dosificación , Relación Dosis-Respuesta a Droga , Inyecciones Intraperitoneales , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/patología , Pruebas de Función Hepática , Masculino , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA